Dr. Marotta is assisting AmoyDx in expanding their operations in Canada. Dr. Marotta also serves as a consultant to a number of companies, and is an Adjunct Professor in the Faculty of Medicine at the University of British Columbia. Prior to working with AmoyDx, Dr. Marotta served as the Chief Scientific Officer at Augurex Life Sciences Corp. At Augurex, Dr. Marotta led the development of the company’s biomarker programs and supported the commercialization of the company’s lead asset, JOINTstat™. During his tenure, Dr. Marotta co-authored 90 scientific publications and assisted the company in receiving significant non-dilutive funding. Dr. Marotta has also held positions in Corporate Development with companies like SignalChem and Stressgen. Dr. Marotta bridges his strong scientific/clinical accumen with business expertise to bring strong value to the companies he works with. Dr. Marotta holds a Ph.D. in Experimental Medicine at the University of British Columbia.